Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of cannabinoid neuroprotection in Huntington's disease
2010-024227-24Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol and dronabinol in Huntington disease (HD), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoints: Safety and Major side effects and clinical worsening. Started Feb 2011; status: completed.
02
Drugs
cannabidioldronabinol
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2010-024227-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024227-24.